Transfer of monoclonal antibodies into breastmilk in neurologic and non-neurologic diseases.

Sara C LaHueAnnika Anderson Kristen M KryskoAlice RutatangwaMorna J DorseyThomas HaleUma MahadevanElizabeth E RogersMelissa G RosensteinRiley Bove

Published in: Neurology(R) neuroimmunology & neuroinflammation (2020)

The current data are reassuring for low mAb drug transfer to breastmilk, but further studies are needed, including of longer-term effects on infant immunity and childhood development.

Keyphrases

electronic health record
big data
case control
gestational age
emergency department
electron transfer
machine learning
monoclonal antibody
childhood cancer
drug induced